We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.13B
AUM Growth
-$2.03B
Cap. Flow
+$382B
Cap. Flow %
4,191.08%
Top 10 Hldgs %
16.25%
Holding
592
New
147
Increased
69
Reduced
127
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Industrials 17.44%
3 Financials 11.93%
4 Healthcare 11.85%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECYT
351
DELISTED
Endocyte, Inc. Common Stock
ECYT
$958K 0.01%
+53,945
New +$926K
IMGN
352
DELISTED
Immunogen Inc
IMGN
$947K 0.01%
+100,000
New +$961K
SEND
353
DELISTED
SendGrid, Inc.
SEND
$935K 0.01%
25,408
-568,952
-96% -$17.9M
AFSI
354
DELISTED
AmTrust Financial Services, Inc.
AFSI
$931K 0.01%
64,101
+44,801
+232% +$652K
VKTX icon
355
Viking Therapeutics
VKTX
$4B
$912K 0.01%
+52,362
New +$623K
CTOS icon
356
CALL
Custom Truck One Source
CTOS
$2.37B
$888K 0.01%
600,001
MAT icon
357
Mattel
MAT
$4.23B
$867K 0.01%
55,212
-696,551
-93% -$11.1M
TNDM icon
358
Tandem Diabetes Care
TNDM
$1.56B
$857K 0.01%
+20,000
New +$698K
VRCA icon
359
Verrica Pharmaceuticals
VRCA
$87.3M
$839K 0.01%
5,160
-1,845
-26% -$315K
ASMB icon
360
Assembly Biosciences
ASMB
$529M
$803K 0.01%
+1,803
New +$845K
ATXS
361
CALL
DELISTED
Astria Therapeutics
ATXS
$800K 0.01%
16,667
ZGNX
362
DELISTED
Zogenix, Inc.
ZGNX
$780K 0.01%
+15,735
New +$801K
TCDA
363
DELISTED
Tricida, Inc. Common Stock
TCDA
$764K 0.01%
25,000
VTAK icon
364
Catheter Precision
VTAK
$1.01M
0
MU icon
365
Micron Technology
MU
$991B
$719K 0.01%
15,894
-395,787
-96% -$20M
ECOR icon
366
electroCore
ECOR
$72.9M
$700K 0.01%
3,337
KDMN
367
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
$668K 0.01%
200,000
ASND icon
368
Ascendis Pharma A/S
ASND
$16.8B
$638K 0.01%
9,000
-28,190
-76% -$1.94M
JPM icon
369
JPMorgan Chase
JPM
$950B
$630K 0.01%
5,587
-36,210
-87% -$4.11M
AMR
370
CALL
DELISTED
Alta Mesa Resources Inc
AMR
$607K 0.01%
145,208
MASI
371
DELISTED
Masimo
MASI
$602K 0.01%
4,831
-219,644
-98% -$24.4M
EIGR
372
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$600K 0.01%
+1,667
New +$570K
TBIO
373
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$600K 0.01%
60,000
GD icon
374
General Dynamics
GD
$106B
$567K 0.01%
2,770
-25,634
-90% -$5.02M
PACK icon
375
CALL
Ranpak Holdings
PACK
$473M
$565K 0.01%
500,001

Similar funds

Alyeska Investment Group's Q3 2018 Portfolio in Review

As of Q3 2018, Alyeska Investment Group held 592 positions worth $9.13B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $382B of net new capital in Q3 2018, opening 147 new positions and adding to 69 existing holdings. Its largest new stake was Marvell Technology: 6,576,490 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $144M trimmed.

  • Alyeska Investment Group's largest Q3 2018 buy was Marvell Technology: 6,576,490 shares worth $127M.
  • Alyeska Investment Group added most to Electronic Arts in Q3 2018, an estimated $185M increase.
  • Alyeska Investment Group's biggest Q3 2018 reduction was Palo Alto Networks, cutting an estimated $144M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q3 2018, selling an estimated $201M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $9.13B portfolio in Q3 2018.
  • Alyeska Investment Group opened 147 new positions and closed 192 in Q3 2018.
  • Alyeska Investment Group's portfolio value fell 18% quarter-over-quarter to $9.13B.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.